Vistagen therapeutics to report 2021 fiscal year end financial results, provide a business update and host conference call and webcast june 29, 2021

South san francisco, calif., june 25, 2021 (globe newswire) -- vistagen therapeutics, inc . (nasdaq: vtgn), a biopharmaceutical company committed to developing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression, and other central nervous system (“cns”) disorders, today announced that it will host a corporate update conference call on tuesday, june 29, 2021 at 2:00 pm pacific time (5:00 pm eastern time) to discuss its financial and operating results for its fiscal year ended march 31, 2021 and provide a business update.
VTGN Ratings Summary
VTGN Quant Ranking